期刊文献+

CD40-ATP-P2X7/NLRP3炎症信号通路在糖尿病视网膜病变中的作用研究进展 被引量:5

Research progress of the CD40-ATP-P2X7/NLRP3 inflammatory pathway in diabetic retinopathy
下载PDF
导出
摘要 糖尿病视网膜病变是糖尿病的严重并发症。炎症反应在糖尿病视网膜病变的发生发展中起着重要的作用。在高糖状态下,糖尿病患者视网膜胶质细胞以及血管内皮细胞间通过CD40-ATP-P2X7受体信号通路相互作用,诱发视网膜神经血管单元炎症级联反应,造成中低度慢性炎症及视网膜损伤。本文回顾糖尿病视网膜病变炎症机制的研究进展,对近年来CD40-ATP-P2X7/NLRP3炎症信号通路参与糖尿病视网膜病变的临床及实验研究进行综述,探讨糖尿病视网膜病变中针对该通路可能的治疗策略。 Diabetic retinopathy(DR)is a serious complication of diabetes,in which inflammation response plays an important role.In the high-glucose state,retinal glial cells interact with vascular endothelial cells in diabetic patients through the CD40-ATP-P2X7 receptor signaling pathway,thus inducing the inflammatory cascade reaction of retinal neurovascular units,and resulting in moderate to low degree chronic inflammation and retinal damage.This study retrospectively reviewed the research progress on the inflammatory mechanism of DR,and summarized latest clinical and experimental studies on the involvement of the CD40-ATP-P2X7/NLRP3 signaling pathway in DR.We also discuss the possible therapeutic strategies targeting this pathway in DR.
作者 孔慧 崔彦 KONG Hui;CUI Yan(Shandong Traditional Chinese Medicine University,Jinan 250022,Shandong Province,China;Deparment of Ophthalmology,Qilu Hospital of Shandong University,Jinan 250012,Shandong Province,China)
出处 《眼科新进展》 CAS 北大核心 2021年第9期879-882,891,共5页 Recent Advances in Ophthalmology
基金 国家自然科学基金资助(编号81100658) 山东省自然科学基金资助(编号ZR2020MH174)。
关键词 糖尿病视网膜病变 炎症 三磷酸腺苷 炎性小体NLRP3 视网膜神经血管单元 胶质细胞 diabetic retinopathy inflammation adenosine triphosphate NLRP3 retinal neurovascular unit glial cells
  • 相关文献

参考文献3

二级参考文献41

  • 1Zhong-Fu Zuo,Qiang Zhang,Xue-Zheng Liu.Protective effects of curcumin on retinal Müller cell in early diabetic rats[J].International Journal of Ophthalmology(English edition),2013,6(4):422-424. 被引量:5
  • 2Bo-Jie Hu,Ya-Nan Hu,Song Lin,Wen-Jiang Ma,and Xiao-Rong Li.Application of Lutein and Zeaxanthin in nonproliferative diabetic retinopathy[J].International Journal of Ophthalmology(English edition),2011,4(3):303-306. 被引量:3
  • 3Li ZG, Sima AA. C-peptide and central nervous system complications !n diabetes: Exp Diabesity Res 2004; 5: 79-90.
  • 4Sima AA, Kamiya H, Li ZG. Insulin, C-peptide, hyperglycemia, and central nervous system complications in diabetes. Eur J Pharmacol 2004; 490: 187-97.
  • 5Li ZG, Zhang W, Grunberger G, Sima AA. Hippocampal neuronal apoptosis in type I diabetes. Brain Res 2002; 946: 221-31.
  • 6Ceriello A, Quatraro A, Giugliano D. Diabetes mellitus and hyperten- sion: the possible role of hyperglycaemia through oxidative stress. Diabetologia 1993; 36: 265-6.
  • 7Sima AA. New insights into the metabolic and molecular basis for diabetic neuropathy. Cell Mol Life Sci 2003; 60: 2445-64.
  • 8Makimattila S, Malmberg-Ceder K, Hakkinen AM, Vuori K, Salenen O, Summanen P, et al. Brain metabolic alterations in patients with type 1 diabetes-hyperglycemia-induced injury. J Cereb Blood Flow Metab 2004; 24: 1393-9.
  • 9Knudsen GM, Jakobsen J, Barry DI, Compton AM, Tomlinson DR. Myo- inositol normalizes decreased sodium permeability of the blood-brain barrier in streptozotocin diabetes. Neuroscience 1989; 29: 773-7.
  • 10Sredy J, Sawicki DR, Notvest RR. Polyol pathway activity in nervous tissues of diabetic and galactose-fed rats: effect of dietary galactose withdrawal or tolrestat intervention therapy. J Diabet Complications 1991; 5: 42-7.

共引文献25

同被引文献59

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部